Article
Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
1 Jan 2023
Abstract excerpt
The relationship between neoantigen recognition by T cells and the clinical success of cancer immunotherapy is beyond doubt.1, 2 Personalized neoantigen-based cancer vaccines and neoantigen-specific T-cell therapy represent promising cancer treatments.3 Challenges yet remain to unleash the full potential of mutanome-based cancer immunotherapy. Among them, the identification and validation of clinically-relevant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
